Immunic names Michael Bonney as board chair

Go back to Immunic names Michael Bonney as board chair

Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors

May 19, 2026 6:30 AM EDT

More Than 30 Years of Leadership Experience Across Biopharmaceutical Commercialization

Played Key Role in the Launch and Commercial Success of Avonex® for Multiple Sclerosis

NEW YORK, May 19, 2026 /PRNewswire/ -- Immunic, Inc. (Nasdaq:... More